Reimbursement

Pharmacy Urges Decisive Action to Close DIR Fee Loophole, Appreciates Senate Finance Committee’s Initial Bipartisan Movement on Issue “DIR relief means closing the loophole that is over-charging seniors and Medicare and making it unsustainable for pharmacies. DIR relief is essential for any drug-pricing legislation”

admin2019-07-25T17:02:08-04:00Categories: Press Release|Tags: Congress, DIR, Medicare, Reimbursement|

“DIR relief means closing the loophole that is over-charging seniors and Medicare and making it unsustainable for pharmacies. DIR relief is essential for any drug-pricing legislation”

DIR Fee Relief Urgency Clear at NACDS Board Member D.C. Fly-in

admin2019-07-19T07:46:26-04:00Categories: Article|Tags: Congress, DIR, Reimbursement|

NACDS Board of Directors members met with key members of Congress in Washington, D.C., to convey the urgent need for DIR fee relief.

DIR Fee Relief Urged in NACDS’ New Cable, Broadcast, Digital Ads NACDS: “Dire” problem for patients, pharmacies must be fixed in drug-pricing bill

admin2019-07-16T08:36:34-04:00Categories: Press Release|Tags: DIR, Medicare, Public_Relations, Reimbursement|

NACDS: “Dire” problem for patients, pharmacies must be fixed in drug-pricing bill

Need for DIR Fee Relief Hits Home for Congress

admin2019-07-11T17:59:17-04:00Categories: Article|Tags: Congress, DIR, Reimbursement, RxIMPACT|

During the Fourth of July congressional recess, members of Congress learned firsthand about key pharmacy issues—particularly about the need for direct and indirect remuneration (DIR) fee relief as part of a drug-pricing legislative package.

105 U.S. Reps., 28 U.S. Senators Urge Trump Administration to Fix Pharmacy DIR Fees Pharmacy groups unite to laud bipartisan Congressional focus on closing the loophole that inflates drug costs for patients and Medicare, and jeopardizes pharmacies

admin2019-06-20T10:17:10-04:00Categories: Press Release|Tags: Congress, DIR, Medicare, Reimbursement|

Pharmacy groups unite to laud bipartisan Congressional focus on closing the loophole that inflates drug costs for patients and Medicare, and jeopardizes pharmacies.

Pharmacy United in Call for President Trump to Act on DIR Fee Reform Bipartisan support is strong for a legislative fix to the loophole that inflates drug costs for patients and for Medicare, and that jeopardizes pharmacies

admin2019-06-10T14:25:32-04:00Categories: Press Release|Tags: DIR, Medicare, Reimbursement|

Bipartisan support is strong for a legislative fix to the loophole that inflates drug costs for patients and for Medicare, and that jeopardizes pharmacies.

DIR Fee Relief is Focus of Largest-Ever NACDS RxIMPACT Push Effort underway to help advance Phair Pricing Act

admin2019-06-07T12:34:18-04:00Categories: Article|Tags: DIR, Medicare, Reimbursement, RxIMPACT|

DIR fee relief is motivating a record-breaking NACDS RxIMPACT Congressional letter-writing campaign. The effort to end the abuse of DIR fees includes three focuses right now. Learn more.

DIR Fee Relief Key in Senate HELP Committee Remarks

admin2019-06-07T12:32:41-04:00Categories: Article|Tags: Congress, DIR, Reimbursement|

NACDS emphasized the need for Congress to address direct and indirect remuneration (DIR) fee relief as it considers solutions to reduce healthcare costs.

Pharmacy “DIR Fee” Loophole Must Close, NACDS RxIMPACT Urges Grassroots engagement supporting Phair Pricing Act is crucial for pharmacy viability and to reduce seniors' out-of-pocket drug costs

admin2019-05-28T14:19:58-04:00Categories: Press Release|Tags: DIR, Medicare, Reimbursement, RxIMPACT|

Grassroots engagement supporting Phair Pricing Act is crucial for pharmacy viability and to reduce seniors' out-of-pocket drug costs.

NCPA, NACDS Statement on Drug Pricing Rule’s Failure to Reform Pharmacy DIR

admin2019-05-16T17:56:09-04:00Categories: Press Release|Tags: DIR, Medicare, Reimbursement|

NCPA and NACDS: "We are disappointed and frustrated that this final rule fails to finalize pharmacy DIR reform as proposed, to the detriment of seniors and community pharmacies. Our organizations have been joined by many pharmacists, pharmacy stakeholder groups, patient advocacy organizations, patients, and members of Congress in advocating that all pharmacy price concessions be included at the point of sale – or eliminated altogether – to provide senior patients with lower costs and pharmacies with more certainty..."

National Association of Chain Drug StoresPharmacies. The face of neighborhood healthcare.